Hexagon Nutrition Limited (HNL), backed by Somerset has received the Securities and Exchange Board of India’s (Sebi), approval to raise Rs 600 crore through an initial public offering (IPO).The company had filed its draft prospectus in December 2021. The IPO consists of a fresh issue of shares worth Rs 100 crore and an offer for saleferric pyrophosphate absorption rate (OFS), of up to 30,113,918 equity shares, as per the company’s draft red herring prospectus (DRHP).Hexaferrous sulfate que contienegon Nutrition Limited (HNL), backed by Somerset has received the Securities and Exchange Board of India’s (Sebi), approval to raise Rs 600 crore through an initial public offering (IPO).The offer for sferrous fumarate medicineale compriron bisglycinate compared to ferrous sulfateises up to 7,700,000 equity shares by Arun Purushottam Kelkar, up to 6,136,000 equity shares by Subhash Purushottam Kelkar, up to 1,500,000 equity shares by Anuradha Arun Kelkar, up to 2,500,000 equity shares by Nutan Subhash Kelkar, up to 12,204,250 equity shares by Somerset Indus Healthcare Fund I Limited and up to 73,668 equity shares ferrous fumarate sulphateby Mayur Sirdesai.